Primary prevention of sudden cardiac death in children with hypertrophic cardiomyopathy: experience with implantable cardioverter-defibrillators
- 6 March 2025
- journal article
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (1) , 32-41
Abstract
Hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in both adults and children. A crucial issue is identifying children with hypertrophic cardiomyopathy (HCM) who are at high risk of sudden cardiac death and require an implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.Objective. To evaluate the effectiveness of implantable cardioverter defibrillators (ICDs) as the primary prevention of sudden cardiac death in children with hypertrophic cardiomyopathy.Material and methods. Data were collected from a single pediatric center (2009–2024), including 200 children and adolescents with hypertrophic cardiomyopathy, 77 patients underwent implantation of a cardioverter defibrillator for the primary prevention of sudden cardiac death.Results. Appropriate shocks on ventricular tachycardia and ventricular fibrillation occurred in 8 out of 77 patients (10.4%) within 1.25 years (IQR 0.6–3). The median time from implantation to the first discharge was 2 years (IQR 1.2–2.3). The annual frequency of appropriate ICD shocks was 3.5% per year. A direct correlation of the responses on the number of risk factors for sudden cardiac death was obtained. In patients with two or more risk factors, the likelihood of motivated response was 12 times higher than in those with fewer risk factors (OR/OR 12.12; CI 95% 1.47–99.65). The values of 5-year risk of sudden cardiac death >16% (HCM Risk-Kids) and >11.9% (HCM Risk-SCD) had the best prognostic value (AUC 0.738; pConclusion. The high prognostic significance of the factorial approach to the stratification of the risk of SCD in children with HCM has been established. It is necessary to further improve the cut-off points for determining indications for implantation of cardioverter defibrillators in children based on 5-year models of sudden cardiac death in pediatric patients.Keywords
This publication has 19 references indexed in Scilit:
- Evaluation of new predictive scores for sudden cardiac death in childhood hypertrophic cardiomyopathy in a French cohortArchives of Cardiovascular Diseases, 2024
- 2023 ESC Guidelines for the management of cardiomyopathiesEuropean Heart Journal, 2023
- Thirty-year outcome in children with hypertrophic cardiomyopathy based on the typeJournal of Cardiology, 2022
- Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyEuropean Heart Journal, 2021
- 227A novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)European Heart Journal, 2019
- Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic EventsJAMA Cardiology, 2018
- How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low MortalityJAMA Cardiology, 2016
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic CardiomyopathyJACC, 2013
- Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathyEuropean Heart Journal, 2008